scispace - formally typeset
N

Niren Murthy

Researcher at University of California, Berkeley

Publications -  158
Citations -  13925

Niren Murthy is an academic researcher from University of California, Berkeley. The author has contributed to research in topics: Drug delivery & In vivo. The author has an hindex of 54, co-authored 151 publications receiving 12120 citations. Previous affiliations of Niren Murthy include The Wallace H. Coulter Department of Biomedical Engineering & Emory University.

Papers
More filters
Journal ArticleDOI

Programming the magnitude and persistence of antibody responses with innate immunity.

TL;DR: It is demonstrated that immunization of mice with synthetic nanoparticles containing antigens plus ligands that signal through TLR4 and TLR7 induces synergistic increases in antigen-specific, neutralizing antibodies compared to immunization with nanoparticles minus a single TLR ligand, and there was enhanced persistence of germinal centres and of plasma-cell responses, which persisted in the lymph nodes for >1.5 years.
Journal ArticleDOI

Dissolving polymer microneedle patches for influenza vaccination

TL;DR: Dissolving microneedle patches can provide a new technology for simpler and safer vaccination with improved immunogenicity that could facilitate increased vaccination coverage.
Journal ArticleDOI

Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestines

TL;DR: It is demonstrated that orally administered TKNs loaded with siRNA against the proinflammatory cytokine tumour necrosis factor-alpha (TNF- α) diminish TNF-α messenger RNA levels in the colon and protect mice from ulcerative colitis.
Journal ArticleDOI

Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair

TL;DR: It is demonstrated that a delivery vehicle composed of gold nanoparticles conjugated to DNA and complexed with cationic endosomal disruptive polymers can deliver Cas9 ribonucleoprotein and donor DNA into a wide variety of cell types and efficiently correct the DNA mutation that causes Duchenne muscular dystrophy in mice via local injection, with minimal off-target DNA damage.
Journal ArticleDOI

Maleimide Cross‐Linked Bioactive PEG Hydrogel Exhibits Improved Reaction Kinetics and Cross‐Linking for Cell Encapsulation and In Situ Delivery

TL;DR: Engineered polyethylene glycol-maleimide matrices for regenerative medicine exhibit improved reaction efficiency and wider range of Young’s moduli by utilizing maleimide cross-linking chemistry.